Minimal residual disease in acute myeloid leukemia is predicted by P-glycoprotein activity but not by multidrug resistance protein activity at diagnosis.

M.A. van der Pol, N. Feller, G.J. Ossenkoppele, GW Weijers, A.H. Westra, A. van Stijn, H.J. Broxterman, G.J. Schuurhuis

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1674-7
JournalLeukemia
Volume17
Issue number8
DOIs
Publication statusPublished - 2003

Cite this